BioCorRx Inc. (BICX)
USD 0.43
(-14.0%)
USD 0.43
(-14.0%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 3.89 Million USD | 1426.47% |
| 2022 | 255.17 Thousand USD | -47.9% |
| 2021 | 489.83 Thousand USD | -6.21% |
| 2020 | 522.26 Thousand USD | 21.98% |
| 2019 | 428.16 Thousand USD | 106.32% |
| 2018 | 207.52 Thousand USD | -89.71% |
| 2017 | 2.01 Million USD | 192.7% |
| 2016 | 688.78 Thousand USD | 12355.39% |
| 2015 | 5530.00 USD | -99.0% |
| 2014 | 553.05 Thousand USD | -30.19% |
| 2013 | 792.21 Thousand USD | 0.0% |
| 2012 | - USD | 0.0% |
| 2011 | - USD | 0.0% |
| 2010 | - USD | 0.0% |
| 2009 | - USD | 0.0% |
| 2008 | - USD | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q2 | 4.13 Million USD | -0.5% |
| 2024 Q1 | 4.01 Million USD | -0.49% |
| 2023 Q1 | 218.6 Thousand USD | -14.33% |
| 2023 Q3 | 143.16 Thousand USD | -21.03% |
| 2023 FY | 3.89 Million USD | 1426.47% |
| 2023 Q4 | 3.89 Million USD | 2620.75% |
| 2023 Q2 | 181.29 Thousand USD | -17.07% |
| 2022 Q1 | 3.17 Million USD | 547.89% |
| 2022 Q3 | 290.72 Thousand USD | -33.04% |
| 2022 Q2 | 434.2 Thousand USD | -86.32% |
| 2022 FY | 255.17 Thousand USD | -47.9% |
| 2022 Q4 | 255.17 Thousand USD | -12.23% |
| 2021 FY | 489.83 Thousand USD | -6.21% |
| 2021 Q4 | 489.83 Thousand USD | -7.18% |
| 2021 Q3 | 527.73 Thousand USD | -6.47% |
| 2021 Q2 | 564.27 Thousand USD | 17.34% |
| 2021 Q1 | 480.87 Thousand USD | -7.92% |
| 2020 Q2 | 403.09 Thousand USD | -1.01% |
| 2020 Q3 | 550.22 Thousand USD | 36.5% |
| 2020 FY | 522.26 Thousand USD | 21.98% |
| 2020 Q4 | 522.26 Thousand USD | -5.08% |
| 2020 Q1 | 407.21 Thousand USD | -4.89% |
| 2019 Q1 | - USD | -100.0% |
| 2019 Q4 | 428.16 Thousand USD | 72.8% |
| 2019 Q3 | 247.77 Thousand USD | -4.62% |
| 2019 Q2 | 259.79 Thousand USD | 0.0% |
| 2019 FY | 428.16 Thousand USD | 106.32% |
| 2018 Q4 | 207.52 Thousand USD | -15.62% |
| 2018 Q2 | 284.34 Thousand USD | -88.07% |
| 2018 Q1 | 2.38 Million USD | 18.2% |
| 2018 FY | 207.52 Thousand USD | -89.71% |
| 2018 Q3 | 245.93 Thousand USD | -13.51% |
| 2017 Q2 | 1.26 Million USD | 41.44% |
| 2017 Q3 | 1.64 Million USD | 29.62% |
| 2017 Q4 | 2.01 Million USD | 22.85% |
| 2017 FY | 2.01 Million USD | 192.7% |
| 2017 Q1 | 895.14 Thousand USD | 29.96% |
| 2016 Q2 | 314.74 Thousand USD | -67.18% |
| 2016 Q3 | 501.76 Thousand USD | 59.42% |
| 2016 FY | 688.78 Thousand USD | 12355.39% |
| 2016 Q4 | 688.78 Thousand USD | 37.27% |
| 2016 Q1 | 958.96 Thousand USD | 17241.08% |
| 2015 Q1 | 20.37 Thousand USD | -96.32% |
| 2015 Q2 | 313.28 Thousand USD | 1437.5% |
| 2015 Q3 | 685.00 USD | -99.78% |
| 2015 Q4 | 5530.00 USD | 707.3% |
| 2015 FY | 5530.00 USD | -99.0% |
| 2014 Q2 | 462.97 Thousand USD | -41.28% |
| 2014 Q1 | 788.43 Thousand USD | -0.48% |
| 2014 Q3 | 573.77 Thousand USD | 23.93% |
| 2014 Q4 | 553.05 Thousand USD | -3.61% |
| 2014 FY | 553.05 Thousand USD | -30.19% |
| 2013 Q1 | - USD | 0.0% |
| 2013 Q3 | - USD | 0.0% |
| 2013 Q4 | 792.21 Thousand USD | 0.0% |
| 2013 FY | 792.21 Thousand USD | 0.0% |
| 2013 Q2 | - USD | 0.0% |
| 2012 Q2 | - USD | 0.0% |
| 2012 FY | - USD | 0.0% |
| 2012 Q4 | - USD | 0.0% |
| 2012 Q1 | - USD | 0.0% |
| 2012 Q3 | - USD | 0.0% |
| 2011 Q1 | - USD | 0.0% |
| 2011 Q3 | - USD | 0.0% |
| 2011 Q2 | - USD | 0.0% |
| 2011 FY | - USD | 0.0% |
| 2011 Q4 | - USD | 0.0% |
| 2010 Q1 | - USD | 0.0% |
| 2010 Q3 | - USD | 0.0% |
| 2010 Q4 | - USD | 0.0% |
| 2010 FY | - USD | 0.0% |
| 2010 Q2 | - USD | 0.0% |
| 2009 Q2 | - USD | 0.0% |
| 2009 Q1 | - USD | 0.0% |
| 2009 FY | - USD | 0.0% |
| 2009 Q4 | - USD | 0.0% |
| 2009 Q3 | - USD | 0.0% |
| 2008 FY | - USD | 0.0% |
| 2008 Q1 | - USD | 0.0% |
| 2008 Q4 | - USD | 0.0% |
| 2008 Q3 | - USD | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| The Amacore Group, Inc. | 1.82 Million USD | -113.265% |
| Arem Pacific Corporation | 151.51 Thousand USD | -2470.876% |
| Assisted 4 Living, Inc. | - USD | -Infinity% |
| Bionik Laboratories Corp. | 2.39 Million USD | -62.963% |
| Banyan Corp. | 2.43 Million USD | -60.201% |
| Clearday, Inc. | 25.8 Million USD | 84.907% |
| Dental Patient Care America, Inc. | - USD | -Infinity% |
| Quantum Medical Transport, Inc. | - USD | -Infinity% |
| Empower Clinics Inc. | 1.93 Million USD | -101.737% |
| First Choice Healthcare Solutions, Inc. | 1.28 Million USD | -203.454% |
| Selectis Health, Inc. | 25.17 Million USD | 84.528% |
| Ethema Health Corporation | 20.52 Thousand USD | -18882.515% |
| HealthLynked Corp. | 450 Thousand USD | -765.603% |
| HQDA Elderly Life Network Corp. | - USD | -Infinity% |
| Healthcare Solutions Management Group, Inc. | - USD | -Infinity% |
| JRSIS Health Care Corporation | 24.95 Thousand USD | -15512.072% |
| Comjoyful International Company | - USD | -Infinity% |
| Medical Facilities Corporation | 54.46 Million USD | 92.849% |
| MedSmart Group Inc. | 50 Thousand USD | -7690.424% |
| North America Frac Sand, Inc. | - USD | -Infinity% |
| Nova Leap Health Corp. | 914.05 Thousand USD | -326.146% |
| Nexteligent Holdings, Inc. | - USD | -Infinity% |
| PAO Group, Inc. | - USD | -Infinity% |
| Primemd Inc. | 6.89 Million USD | 43.504% |
| Raffles Medical Group Ltd | 52.43 Million USD | 92.572% |
| Ryman Healthcare Limited | 1.52 Billion USD | 99.744% |
| Stem Cell Authority, Ltd. | - USD | -Infinity% |
| SETO Holdings, Inc. | - USD | -Infinity% |
| Optima Medical Innovations Corp. | 57.07 Thousand USD | -6724.247% |
| Mycotopia Therapies, Inc. | - USD | -Infinity% |
| U.S. NeuroSurgical Holdings, Inc. | 58 Thousand USD | -6615.883% |
| Veltex Corporation | - USD | -Infinity% |
| World Financial Holding Group | - USD | -Infinity% |
| Xcelerate Inc. | - USD | -Infinity% |